ClinicalTrials.Veeva

Menu

GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms (657/10UFCSPA)

P

Phytopharm Consulting Brazil

Status and phase

Unknown
Phase 3

Conditions

Uterus; Hemorrhage, Preclimacteric or Premenopausal
Premenstrual Syndrome

Treatments

Drug: GAMALINE®
Drug: GAMALINE® + HIPERICIN®

Study type

Interventional

Funder types

Other
NETWORK
Industry

Identifiers

NCT01365676
GAM+HIP

Details and patient eligibility

About

2 phytomedicines already in the market: GAMALINE® for premenstrual syndrome and HIPERICIN® as antidepressant will be prescribed together for treating women with Premenstrual Syndrome (PMS) symptoms and vasomotor problems for checking the advantage compared to the GAMALINE® prescription alone.

Full description

Test with 2 female groups: 25-44 years old (reproductive age) and 45-55 years old (climacteric premenopausal age) complaining about all symptoms related with premenstrual syndrome.

Enrollment

240 estimated patients

Sex

Female

Ages

25 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • fertile women between 25-44 years old
  • climacteric women between 45-55 years old

Exclusion criteria

  • inferior age to 25 years old
  • superior age to 55 years old
  • post-menopausal
  • under hormone therapy
  • thyroid disease
  • under psychiatric therapy or medication
  • history for allergies and/or hypersensitivity to any component
  • breast feeding or pregnancy
  • no knowledge for writing and/or reading

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

240 participants in 4 patient groups

GAMALINE® + HIPERICIN® 25-44 years old
Experimental group
Description:
Fertile women 24-44 years old with PMS symptoms
Treatment:
Drug: GAMALINE® + HIPERICIN®
GAMALINE® 25-44 years old
Active Comparator group
Description:
Fertile women 24-44 years old with PMS symptoms
Treatment:
Drug: GAMALINE®
GAMALINE® + HIPERICIN® 45-55 years old
Experimental group
Description:
Climacteric women with PMS symptoms
Treatment:
Drug: GAMALINE® + HIPERICIN®
GAMALINE® 45-55 years old
Active Comparator group
Description:
Climacteric women with PMS symptoms
Treatment:
Drug: GAMALINE®

Trial contacts and locations

1

Loading...

Central trial contact

Gustavo Remus, Physical Education; Marli Chaves, Secretary

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems